Over the past few years we have seen enormous changes on the R&D side of the pharma industry. Mergers big and little have spawned plans to shave costs and many, many research jobs. Struggling to clear a path through a dangerous thicket of patent expirations and risky trials to a bright new future, companies have been overhauling development plans and highlighting new disease arenas as they shutter programs for some of their long-term favorites. And the rapid changes have been felt around the globe.
FiercePharma analyzed the numbers and came up with the top 15 pharma R&D budgets around the world, with some additional insights into the companies' discovery strategies. Next week, we'll tackle the top 15 biotech companies on the list. Click here to get the details on Pharma's 15 biggest spenders. Full Report